Women and men alike experience hormonal shifts during treatment
In May 2026, Novo Nordisk is set to showcase its expansive cardiometabolic and diabetes pipeline at the American Diabetes Associations (ADA) 2026 Scientific Sessions, presenting a total of 40 abstracts
Note: Market size and forecast figures in this report are generated using Mordor Intelligences proprietary estimation framework, updated with the latest available data and insights as of 2026
The most common side effects are nausea, vomiting, diarrhea, and stomach pain, including a potential fast heartbeat
By 2024, Ozempic sales were over $18 billion annually and still growing
Check if any of the expenses are insurable, which is rare